NCT01996865 2025-07-10
MAGNIFY
Celgene
Phase 3 Completed
Clinical Trials
4 trialsNCT01865110 2025-03-05
R-CHOP + R-HAD vs R-CHOP Followed by Maintenance Lenalidomide + Rituximab vs Rituximab for Older Patients With MCL
The Lymphoma Academic Research Organisation
Phase 3 Completed
NCT01021423 2019-11-19
RENEW
Celgene
Phase 3 Terminated
NCT02354313 2018-02-09
MCL0208
Fondazione Italiana Linfomi - ETS
Phase 3 Unknown